SEC Form 4 · accession 0001193125-26-277509
Beam Therapeutics Inc. · BEAM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Giuseppe Ciaramella
Officer — President
Period of report
Jun 17, 2026
Accepted (ET)
Jun 22, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001745999
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 17, 2026 | M | 6,505 | $0.67 | A | 224,911 | D | |
| Common Stock | Jun 17, 2026 | M | 29,000 | $1.03 | A | 253,911 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.67 | Jun 17, 2026 | M | 6,505 | D | — | May 8, 2028 | Common Stock | 6,505 | 0 | D |
| Stock Option (Right to Buy)F1 | $1.03 | Jun 17, 2026 | M | 29,000 | D | — | Jul 13, 2028 | Common Stock | 29,000 | 56,946 | D |
Explanation of responses
- F1The shares subject to these stock options vested 25% on the first anniversary of the vesting commencement dates, February 26, 2018, and the remaining shares vested in 36 substantially equal monthly installments thereafter.